Skip to main content
Log in

Hypertension

Relationship with Other Risk Factors

  • Published:
Drugs Aims and scope Submit manuscript

Summary

Elevated blood pressure is a major contributor to cardiovascular disease in general and to coronary heart disease in particular, now its most common sequela. The risk is proportional to the degree of blood pressure elevation, at all ages and in either sex, whether the increased pressure is labile or fixed, diastolic or systolic in character.

The effect of blood pressure on cardiovascular disease incidence is independent of the influence of other predisposing co-factors, but the hazard is greatly influenced by them. Elevated pressures are often accompanied by hyperlipidaemia, hyperuricaemia, overweight, hyperglycaemia, elevated fibrinogen values and ECG abnormalities. The risk associated with any degree of elevation of pressure varies greatly, depending on the number and level of these often associated risk factors, and on whether or not there is the indication of target organ involvement. The excess cardiovascular risk in hypertensive persons tends to be concentrated in those with an increased LDL/HDL cholesterol ratio, impaired glucose tolerance, cigarette smokers and those with accompanying ECG abnormalities.

Hypertension is best conceptualised as a component of a multivariate cardiovascular risk profile which provides a sound basis for determining urgency for drug treatment. Optimal preventive management of hypertension requires multifactorial correction of all disordered components of the cardiovascular risk profile before occurrence of target organ involvement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Dustan HP. Role of hypertension and its control-experimental aspects. Progress in Biochemical Pharmacology 19: 177–191, 1983

    CAS  PubMed  Google Scholar 

  • Gordon T, Kannel WB, Castelli WP, et al. Lipoproteins, cardiovascular disease and death. The Framingham Study. Archives of Internal Medicine 141: 1128–1131, 1981

    Article  CAS  PubMed  Google Scholar 

  • Kannel WB, Sorlie P. Hypertension in Framingham. In Paul (Ed.) Epidemiology and control of hypertension, pp. 553–592. Symposia Specialists, Miami, 1975

  • Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham Study. Annals of Internal Medicine 90: 85–91, 1979

    CAS  PubMed  Google Scholar 

  • Kannel WB, Sorlie P, Gordon T. Labile hypertension: a faulty concept? The Framingham Study. Circulation 61: 1183–1187, 1980a

    Article  CAS  PubMed  Google Scholar 

  • Kannel WB, Dawber TR, McGee DL. Perspectives of systolic hypertension: the Framingham Study. Circulation 61: 1179–1182, 1980b

    Article  CAS  PubMed  Google Scholar 

  • Kannel WB, Wolf PA, McGee DL, et al. Systolic blood pressure, arterial rigidity and risk of stroke. The Framingham Study. Journal of the American Medical Association 245: 1225–1228, 1981

    Article  CAS  PubMed  Google Scholar 

  • Kannel WB, Wolf PA, Verter J. Manifestations of coronary disease predisposing to stroke. Journal of the American Medical Association 250: 2942–2946, 1983

    Article  CAS  PubMed  Google Scholar 

  • Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction. New England Journal of Medicine 311: 1144–1147, 1984

    Article  CAS  PubMed  Google Scholar 

  • Smith WM. Epidemiology of hypertension. Medical Clinics of North America 61: 467–486, 1977

    CAS  PubMed  Google Scholar 

  • Stamler J. Epidemiology and treatment of hypertension. In Carlson and Cunningham (Eds) Future directions in health care: a new public policy. Ballinger, Cambridge, Mass, 1978

    Google Scholar 

  • Tobian LJ. Interrelationships of sodium volume, CNS and hypertension. Progress in Biochemical Pharmacology 19: 208–229, 1983

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kannel, W.B. Hypertension. Drugs 31 (Suppl 1), 1–11 (1986). https://doi.org/10.2165/00003495-198600311-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198600311-00004

Keywords

Navigation